chr22-28734421-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The ENST00000404276.6(CHEK2):​c.301G>A​(p.Asp101Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D101E) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

CHEK2
ENST00000404276.6 missense

Scores

5
14

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.38
Variant links:
Genes affected
CHEK2 (HGNC:16627): (checkpoint kinase 2) In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13116235).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CHEK2NM_007194.4 linkuse as main transcriptc.301G>A p.Asp101Asn missense_variant 2/15 ENST00000404276.6 NP_009125.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CHEK2ENST00000404276.6 linkuse as main transcriptc.301G>A p.Asp101Asn missense_variant 2/151 NM_007194.4 ENSP00000385747 P2O96017-1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461714
Hom.:
0
Cov.:
33
AF XY:
0.00000138
AC XY:
1
AN XY:
727140
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
31
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Uncertain
0.028
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.11
T;.;T;T;.;T;.;.;.;.;T;.;.
Eigen
Benign
-0.014
Eigen_PC
Benign
0.16
FATHMM_MKL
Benign
0.67
D
LIST_S2
Uncertain
0.96
.;D;.;.;D;D;D;.;D;D;D;D;D
M_CAP
Benign
0.045
D
MetaRNN
Benign
0.13
T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.061
T
MutationAssessor
Benign
1.9
L;L;L;L;L;L;L;L;.;.;.;.;.
MutationTaster
Benign
0.68
D;D;D;D;D;D;D;D;N;N;N
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-0.58
N;N;N;N;N;.;N;N;N;N;N;.;.
REVEL
Benign
0.17
Sift
Benign
0.48
T;T;T;T;D;.;D;T;D;T;D;.;.
Sift4G
Benign
0.49
T;T;T;T;T;.;T;T;T;T;T;.;.
Polyphen
0.084
B;B;B;B;B;B;P;B;.;.;.;.;.
Vest4
0.25
MutPred
0.39
Gain of MoRF binding (P = 0.4458);Gain of MoRF binding (P = 0.4458);Gain of MoRF binding (P = 0.4458);Gain of MoRF binding (P = 0.4458);Gain of MoRF binding (P = 0.4458);Gain of MoRF binding (P = 0.4458);Gain of MoRF binding (P = 0.4458);Gain of MoRF binding (P = 0.4458);Gain of MoRF binding (P = 0.4458);Gain of MoRF binding (P = 0.4458);Gain of MoRF binding (P = 0.4458);Gain of MoRF binding (P = 0.4458);Gain of MoRF binding (P = 0.4458);
MVP
0.93
MPC
0.030
ClinPred
0.46
T
GERP RS
5.4
Varity_R
0.11
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs786203283; hg19: chr22-29130409; API